Dergiler / Turkish Journal of Veterinary and Animal Sciences / 2022 / Cilt: 46 - Sayı: 1

The apoptotic and proliferative effects of tulathromycin and gamithromycin on bovine tracheal epithelial cell culture

Sayfa
139–146
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

The increase in epithelial cell proliferation of gamithromycin and tulathromycin due to time shows that these antibiotics can maintain longterm prophylactic treatment against diseases.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Gamithromycin and tulathromycin are commonly used in the treatment of bovine respiratory bacterial diseases.
📊
Temel Bulgular & Veri:The comparison between gamithromycin and tulathromycin concentrations on tracheal cells in terms of % cell viability was found to be significantly different.
💡
Sonuç & Katkı:The increase in epithelial cell proliferation of gamithromycin and tulathromycin due to time shows that these antibiotics can maintain longterm prophylactic treatment against diseases.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Gamithromycin and tulathromycin are commonly used in the treatment of bovine respiratory bacterial diseases. The current work was undertaken to establish the apoptotic, necrotic, and cytotoxic effects of these antibiotics in the target animal. Cells with apoptosis and necrosis were determined by dual staining method, cytotoxic effects were determined by MTT assay, cell proliferative effects were examined by XCelligence real-time cell analysis system (RTCA-SP). The comparison between gamithromycin and tulathromycin concentrations on tracheal cells in terms of % cell viability was found to be significantly different. While the cell viability percentage of gamithromycin was higher at 150 µg/mL, 180 µg/mL, and 240 µg/mL than tulathromycin, and at 2 µg/mL, 4 µg/mL, 10 µg/mL, 20 µg/mL, and 50 µg/mL concentrations tulathromycin cell viability was higher than gamithromycin (p < 0.05). When the staining method data were evaluated, the difference between the results of % apoptotic index at 20 µg/mL concentration was significant and it was found that gamithromycin had more apoptotic effect than tulathromycin (p < 0.05). It was seen that tulathromycin and gamithromycin applied on tracheal epithelial cells at concentrations of 2 and 10 µg/mL increased the viability depending on time. The increase in epithelial cell proliferation of gamithromycin and tulathromycin due to time shows that these antibiotics can maintain longterm prophylactic treatment against diseases.

🔖

Bu Makaleye Atıf Yap

ŞAHİN, Y., YILDIRIM, E., TÜRK, M., DİKMEN, B. Y. (2022). The apoptotic and proliferative effects of tulathromycin and gamithromycin on bovine tracheal epithelial cell culture. Turkish Journal of Veterinary and Animal Sciences, Cilt: 46 - Sayı: 1, 139–146. https://ajindex.com/articles/614538

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Jelić D, Antolović R. From erythromycin to azithromycin and new potential ribosome-binding antimicrobials. Antibiotics (Basel) 2016
  2. 5(3): 29. doi:10.3390/antibiotics5030029 2. Pyörälä S, Baptiste KE, Catry B, Van Duijkeren E, Greko C et al. Macrolides and lincosamides in cattle and pigs: use and development of antimicrobial resistance. The Veterinary Journal 2014
  3. 200(29): 230-239. doi: 10.1016/j.tvjl.2014.02.028 3. Papich MG, Riviere JE. Chloramphenicol and derivatives, macrolides, lincosamides and miscellaneous antimicrobials. In: Adams HR (editor). Veterinary Pharmacology and Therapeutics, 8th ed. Lowa, USA: Blackwell Publishing
  4. pp. 876-882. 4. Anadón A, Reeve-Johnson L. Macrolide antibiotics, drug interactions and microsomal enzymes: implications for veterinary medicine. Research in Veterinary Science 1999
  5. 66(3): 197-203. doi: 10.1053/rvsc.1998.0244 5. Benchaoui HA, Nowakowski M, Sherington J, Rowan TG, Sunderland SJ. Pharmacokinetics and lung tissue concentrations of tulathromycin in swine. Journal of Veterinary Pharmacology and Therapeutics 2004
  6. 27(4): 203-210. doi: 10.1111/j.1365-2885.2004.00586.x 6. Nowakowski MA, Inskeep PB, Risk JE, Skogerbo TL, Benchaoui HA et al. Pharmacokinetics and lung tissue concentrations of tulathromycin, a new triamilide antibiotic, in cattle. Veterinary Therapeutics: Research in Applied Veterinary Medicine 2004
  7. 5(1): 60-74. 7. Papich MG. Chloramphenicol and derivatives, macrolides, lincosamides, and miscellaneous antimicrobials. In: Riviere JE, Papich MG (editors). Veterinary Pharmacology and Therapeutics. 10th ed. Hoboken, USA: John Wiley and Sons
  8. pp. 912-925. 8. Dedonder KD, Apley MD, Li M, Gehring R, Harhay DM et al. Pharmacokinetics and pharmacodynamics of gamithromycin in pulmonary epithelial lining fluid in naturally occurring bovine respiratory disease in multi source commingled feedlot cattle. Journal of Veterinary Pharmacology and Therapeutics 2015
  9. 39(2): 157-166. doi: 10.1111/jvp.12267 9. Hildebrand F, Venner M, Giguére S. Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia. Journal of Veterinary Internal Medicine 2015
  10. 29(1): 333-338. doi: 10.1111/jvim.12504 10. Villarino N, Brown SA, Martín-Jiménez T. The role of the macrolide tulathromycin in veterinary medicine. The Veterinary Journal 2013
  11. 198(2):352-357. doi: 10.1016/j. tvjl.2013.07.032 11. Wyns H, Meyer E, Plessers E, Watteyn A, De Baere S et al. Pharmacokinetics of gamithromycin after intrav